Showing results (71-80 of 188) with videos related to
Sort By:
Pageof 19
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 1995
Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chainsR A Rudick, S V Medendorp, M Namey, et al.Neurology|October 1, 1985
Multiple sclerosis: free light chains in cerebrospinal fluidR A Rudick, D R Peter, J M Bidlack, et al.Archives of Neurology|March 1, 1982
Recovery from the 'locked-in' syndromeE A McCusker, R A Rudick, G W Honch, et al.Annals of Neurology|September 25, 2004
Defining interferon beta response status in multiple sclerosis patientsRichard A Rudick, Jar-Chi Lee, Jack Simon, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1aR A Rudick, E Fisher, J C Lee, et al.Journal of Neuroimmunology|December 8, 2000
Immunomodulatory effects of interferon beta-1a in multiple sclerosisZ Liu, C M Pelfrey, A Cotleur, et al.Archives of Neurology|July 1, 1990
The clinical course of multiple sclerosis during pregnancy and the puerperiumK Birk, C Ford, S Smeltzer, et al.Archives of Neurology|September 15, 2000
Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of lifeD M Miller, R A Rudick, G Cutter, et al.Neurology|October 10, 2001
Axonal loss in normal-appearing white matter in a patient with acute MSC Bjartmar, R P Kinkel, G Kidd, et al.Journal of Neuroimmunology|September 11, 2003
Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cellsPia Kivisäkk, Anne C Cotleur, Jar Chi Lee, et al.Pageof 19